Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract Cancer
- PMID: 38434914
- PMCID: PMC10905280
- DOI: 10.21873/cdp.10301
Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract Cancer
Abstract
Background/aim: Sarcopenia accompanied by systemic inflammation is associated with poor prognosis in patients with cancer. This study evaluated the prognostic significance of sarcopenia (myopenia and myosteatosis) and systemic inflammatory markers in older patients (aged ≥80 years) with resected biliary tract cancer.
Patients and methods: Patients who underwent resection for biliary tract cancer between July 2010 and January 2023 at the NHO Fukuyama Medical Center were retrospectively reviewed. Preoperative computed tomography measured myopenia and myosteatosis, using the psoas muscle index and modified intramuscular adipose tissue content. Associations between clinicopathological characteristics, inflammation-based prognostic scores, and overall survival were analyzed using Cox proportional hazards models.
Results: Univariate analysis revealed low C-reactive protein-to-albumin ratio (<0.125), low prognostic nutritional index (<42), low modified intramuscular adipose tissue content, higher T-stage (T3-4), lymph node metastasis, and postoperative complications associated with worse overall survival in older patients (aged ≥ 80 years) with resected biliary tract cancer (n=48). Multivariate analysis identified low prognostic nutritional index (<42) (p=0.007), low modified intramuscular adipose tissue content (p=0.015), higher T-stage (T3-4) (p<0.001), lymph node metastasis (p=0.001), and postoperative complications (p=0.017) as independent predictors of overall survival.
Conclusion: Preoperative myosteatosis and low prognostic nutritional index are independent prognostic factors for overall survival in older patients (aged ≥80 years) with resected biliary tract cancer. These factors may be useful for risk stratification and clinical decision-making. Early interventions, such as nutritional support and physical exercise, may improve outcomes after resection of biliary tract cancer.
Keywords: Biliary tract neoplasms; inflammation; nutrition assessment; prognosis; sarcopenia.
Copyright 2024, International Institute of Anticancer Research.
Conflict of interest statement
The Authors declare that they have no competing interests.
Figures
Similar articles
-
Prognostic Significance of Sarcopenia and Systemic Inflammatory Markers in Biliary Tract Cancer: A Retrospective Cohort Study.J Gastrointest Cancer. 2024 Jun;55(2):888-899. doi: 10.1007/s12029-024-01034-6. Epub 2024 Feb 26. J Gastrointest Cancer. 2024. PMID: 38403714
-
A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.BMC Gastroenterol. 2021 Oct 13;21(1):375. doi: 10.1186/s12876-021-01957-5. BMC Gastroenterol. 2021. PMID: 34645392 Free PMC article.
-
Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1322-1333. doi: 10.1002/jpen.1171. Epub 2018 May 15. JPEN J Parenter Enteral Nutr. 2018. PMID: 29761898
-
Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis.JPEN J Parenter Enteral Nutr. 2019 May;43(4):508-515. doi: 10.1002/jpen.1459. Epub 2018 Oct 18. JPEN J Parenter Enteral Nutr. 2019. PMID: 30334265
-
Preoperative C-reactive protein-to-albumin ratio as a prognostic factor in biliary tract cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2023 Jun 2;102(22):e33656. doi: 10.1097/MD.0000000000033656. Medicine (Baltimore). 2023. PMID: 37266653 Free PMC article.
Cited by
-
Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy.Cancer Diagn Progn. 2025 Jan 3;5(1):132-137. doi: 10.21873/cdp.10422. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758246 Free PMC article.
-
Prognostic roles nutritional index in patients with resectable and advanced biliary tract cancers.World J Gastroenterol. 2025 Feb 14;31(6):97697. doi: 10.3748/wjg.v31.i6.97697. World J Gastroenterol. 2025. PMID: 39958446 Free PMC article.
References
-
- Buettner S, van Vugt JLA, Gaspersz MP, Coelen RJS, Roos E, Labeur TA, Margonis GA, Ethun CG, Maithel SK, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, IJzermans JNM, van Gulik TM, Pawlik TM, Groot Koerkamp B. Survival after resection of perihilar cholangiocarcinoma inpatients with lymph node metastases. HPB (Oxford) 2017;19(8):735–740. doi: 10.1016/j.hpb.2017.04.014. - DOI - PMC - PubMed
-
- Lim SH, Hong JY, Park JO, Park YS, Kim ST. Pemetrexed and erlotinib as a salvage treatment in patients with metastatic biliary tract cancer who failed gemcitabine-containing chemotherapy: A phase II single-arm prospective study. Anticancer Res. 2023;43(9):4161–4167. doi: 10.21873/anticanres.16607. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials